BioLargo Achieves 111% Growth to a Record $1.5 Million Revenue for Third Quarter 2022
Stock Information for Biolargo Inc
Please wait while we load your information from QuoteMedia.
More Recent News About Biolargo Inc
BioLargo Subsidiary Clyra Medical Technologies Adds Two Medical Industry Veterans to its Board of Directors
BioLargo to Appear on ClearThink IR's Virtual Live Event on Wednesday, January 25, 2023 at 12 Noon ET
BioLargo Q3 2022 Earnings Results Webcast and Conference Call on Wednesday, November 16, 2022 - 5 PM Eastern Time